Gao; Ying-Duo

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gao; Ying-Duo.The latest application filed is for "factor xia inhibitors".

Company Profile

1.23.29

Gao; Ying-Duo - Holmdel NJ
Gao; Ying-Duo - Edison NJ
Gao; Ying-Duo - Meshanie Station NJ
Gao, Ying-Duo - Rahway NJ
Gao; Ying-Duo - Neshanic Station NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Factor XIA inhibitors Grant 10,214,512 - Xu , et al. Feb	2019-02-26
Factor Xia Inhibitors App 20180339977 - Xu; Jiayi ; et al.	2018-11-29
Factor XIa inhibitors Grant 10,123,995 - Mertz , et al. November 13, 2	2018-11-13
Factor XIa inhibitors Grant 10,093,683 - Lim , et al. October 9, 2	2018-10-09
Factor XIa inhibitors Grant 10,081,617 - Mertz , et al. September 25, 2	2018-09-25
Factor XIa inhibitors Grant 10,011,585 - Liu , et al. July 3, 2	2018-07-03
Factor XIa inhibitors Grant 9,975,874 - Mertz , et al. May 22, 2	2018-05-22
FACTOR XIa INHIBITORS App 20180079743 - Mertz; Eric ; et al.	2018-03-22
Factor XIa inhibitors Grant 9,868,727 - Liu , et al. January 16, 2	2018-01-16
FACTOR XIa INHIBITORS App 20180000795 - Mertz; Eric ; et al.	2018-01-04
Factor XIa Inhibitors App 20170240524 - Mertz; Eric ; et al.	2017-08-24
FACTOR XIa INHIBITORS App 20170240523 - Liu; Weiguo ; et al.	2017-08-24
Factor XIa Inhibitors App 20170210732 - Liu; Weiguo ; et al.	2017-07-27
FACTOR XIa INHIBITORS App 20170044183 - Lim; Yeon-Hee ; et al.	2017-02-16
Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitors Grant 9,481,682 - Kim , et al. November 1, 2	2016-11-01
Btk Inhibitors App 20150353570 - KIM; RONALD M. ; et al.	2015-12-10
Btk Inhibitors App 20140206681 - KIM; RONALD M. ; et al.	2014-07-24
Substituted diazepine sulfonamides as bombesin receptor subtype-3 modulators Grant 8,153,626 - Baker , et al. April 10, 2	2012-04-10
Bicyclic pyrimidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes Grant 7,956,061 - Ashton , et al. June 7, 2	2011-06-07
Substituted Diazepine Sulfonamides As Bombesin Receptor Subtype-1 Modulators App 20100317645 - Baker; Robert K. ; et al.	2010-12-16
Pyrazole carboxamides as inhibitors of 11-.beta.-hydroxysteroid dehydrogenase-1 Grant 7,659,408 - Gao , et al. February 9, 2	2010-02-09
Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease Grant 7,531,573 - Brugnara , et al. May 12, 2	2009-05-12
Bicyclic Pyrimidines as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes App 20090105210 - Ashton; Wallace T. ; et al.	2009-04-23
Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes Grant 7,482,336 - Biftu , et al. January 27, 2	2009-01-27
Pyrazole Carboxamides as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1 App 20080153893 - Gao; YIng-Duo ; et al.	2008-06-26
Ophthalmic Compositions for Treating Ocular Hypertension App 20080097108 - Gao; Ying-Duo ; et al.	2008-04-24
Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation Grant 7,342,038 - Brugnara , et al. March 11, 2	2008-03-11
Ophthalmic Compositions for Treating Ocular Hypertension App 20070293558 - Gao; Ying-Duo ; et al.	2007-12-20
Aminocyclohexanes as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes App 20070254865 - Biftu; Tesfaye ; et al.	2007-11-01
Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation Grant 6,992,079 - Brugnara , et al. January 31, 2	2006-01-31
Ophthalmic compositions for treating ocular hypertension Grant 6,864,383 - Garcia , et al. March 8, 2	2005-03-08
Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation App 20040242563 - Brugnara, Carlo ; et al.	2004-12-02
Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation Grant 6,800,658 - Brugnara , et al. October 5, 2	2004-10-05
Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease App 20040127464 - Brugnara, Carlo ; et al.	2004-07-01
Spiro-indolines as Y5 receptor antagonists App 20040063942 - Gao, Ying-Duo ; et al.	2004-04-01
Ophthalmic compositions for treating ocular hypertension App 20040054213 - Garcia, Maria L. ; et al.	2004-03-18
Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation App 20040002486 - Brugnara, Carlo ; et al.	2004-01-01
Spiro-indolines as Y5 receptor antagonists Grant 6,638,942 - Gao , et al. October 28, 2	2003-10-28
Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation App 20030191111 - Brugnara, Carlo ; et al.	2003-10-09
Methods For The Treatment Or Prevention Of Inflammatory Diseases Characterized By Abnormal Cell Proliferation App 20030134842 - BRUGNARA, CARLO ; et al.	2003-07-17
Substitute 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation Grant 6,534,497 - Brugnara , et al. March 18, 2	2003-03-18
Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation App 20020198188 - Brugnara, Carlo ; et al.	2002-12-26
Methods for the treatment or prevention of inflammatory diseases characterized by abnormal cell proliferation App 20020128256 - Brugnara, Carlo ; et al.	2002-09-12
Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease App 20020119953 - Brugnara, Carlo ; et al.	2002-08-29
Spiro-indolines as Y5 receptor antagonists App 20020058813 - Gao, Ying-Duo ; et al.	2002-05-16
Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease Grant 6,331,564 - Brugnara , et al. December 18, 2	2001-12-18
Spiro-indolines as Y5 receptor antagonists Grant 6,313,298 - Gao , et al. November 6, 2	2001-11-06
Spiro-indolines as Y5 receptor antagonists Grant 6,191,160 - Gao , et al. February 20, 2	2001-02-20
Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation Grant 6,028,103 - Brugnara , et al. February 22, 2	2000-02-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.